Status:
COMPLETED
Study of the Osteoprotector Effects of a Milk Product Based on Anthocyans and Enriched in Calcium and Vitamin D
Lead Sponsor:
Elvir SAS
Collaborating Sponsors:
University Hospital, Clermont-Ferrand
Conditions:
Osteoporosis
Eligibility:
FEMALE
50-65 years
Phase:
PHASE2
Brief Summary
We hypothesize that anthocyans with calcium and vitamin D have a positive effect on bone reshaping in menopausal women.
Eligibility Criteria
Inclusion
- Women
- Aged between 50 and 65 years
- Between 1 and 5 years menopause
- IMC between 19 and 30 kg/m²
Exclusion
- Medical Treatment for bone metabolism
- Vitamin D not including in the range of 20nmoles\<25(OH)\<100nmoles/l
- Vegan and vegetarian diet
- Regular consumption of food supplementary benefits
- Lactose intolerance
- While dieting
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00663221
Start Date
March 1 2008
Last Update
July 7 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63